| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/01/2003 | US20030082207 Method of using HIV protease inhibiting compounds |
| 05/01/2003 | US20030082190 Fusion molecules and treatment of IgE-mediated allergic diseases |
| 05/01/2003 | US20030082117 Genus leontopodium plant extract and compositions containing same |
| 05/01/2003 | CA2466813A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors |
| 05/01/2003 | CA2464593A1 6-hydroxy isoflavones, derivatives and medicaments involving same |
| 05/01/2003 | CA2464344A1 Ee3-protein family and corresponding dna sequences |
| 05/01/2003 | CA2464331A1 Allium sativum bulb absolutes and therapeutic or cosmetic uses |
| 05/01/2003 | CA2464111A1 Phosphonic acid compounds as inhibitors of serine proteases |
| 05/01/2003 | CA2464085A1 A combination product comprising melagatran and dexamethasone |
| 05/01/2003 | CA2463951A1 Solid pharmaceutical formulation for a piperazine urea derivative |
| 05/01/2003 | CA2463311A1 Androgen receptor modulators and methods of use thereof |
| 05/01/2003 | CA2463309A1 Sterile, breathable patch for treating wound pain |
| 05/01/2003 | CA2463282A1 Therapeutical agent for pruritus |
| 05/01/2003 | CA2463101A1 Azole derivatives and pharmaceutical compositions containing them |
| 05/01/2003 | CA2461182A1 Use of tyrosine kinase inhibitors for promoting hair growth |
| 05/01/2003 | CA2458542A1 Enzyme inhibitors for inactivating allergens |
| 04/30/2003 | DE20209391U1 Ointment for treating dry, stressed or wounded skin comprises olive oil, sea buckthorn oil, a fragrance oil and an ointment base |
| 04/30/2003 | CN1414967A Silicon compounds derived from ascorbic acid, preparation method, composition containing the compounds and application |
| 04/30/2003 | CN1414965A Sulfonamides and derivatives thereof that modulate the activeity of endothelin |
| 04/30/2003 | CN1414961A Substituted oximes and hydrazones as neurokinin antagonists |
| 04/30/2003 | CN1414960A Substituted piperidines, medicaments containing these compounds, and methods for production thereof |
| 04/30/2003 | CN1414864A Adhesive particle DNA constructs and method of making and using the same |
| 04/30/2003 | CN1414858A Combinations of receptor tyrosine kinase inhibitor with a1-acidic glycoprotein binding organic compound |
| 04/30/2003 | CN1414856A Antiprurity agents for external use |
| 04/30/2003 | CN1414855A Remedies for external use for allergic skin diseases |
| 04/30/2003 | CN1414101A Desmocyte growth factor 11 |
| 04/30/2003 | CN1413720A Chinese drugs for treating psoriasis and its preparation method |
| 04/30/2003 | CN1413717A Chinese medicineal powder for treating alopecia areata, male pattern alopecia and juvenile hoary hair |
| 04/30/2003 | CN1413660A Chinese medicine powder for treating damp-heat venenata dermatosis and its preparation method |
| 04/30/2003 | CN1413636A Ginkgo exosperm water-solubale composite with drug effect and extraction method |
| 04/30/2003 | CN1413628A External used medicine for treating external wound and its production method and application |
| 04/30/2003 | CN1413627A Medicine for treating dematosis |
| 04/30/2003 | CN1413619A Sheqi facial appearance capsule and its preparation technology |
| 04/30/2003 | CN1413613A Medicine for anti-microwave, radiation and reducing toxic and side effect of radiotherapy and chemotherapy and its preparation method |
| 04/30/2003 | CN1413611A Natural oral preparation for prevention and curing acne and brandy nose |
| 04/30/2003 | CN1413596A Yoghurt containing ossein protein capsule, chewing tablet and its preparation method |
| 04/30/2003 | CN1413593A Medicine for curing dermatosis |
| 04/30/2003 | CN1413592A Ointment for curing multiple dermatosis |
| 04/30/2003 | CN1413573A Freckle eliminate face-beautying cream and making technology |
| 04/30/2003 | CN1413572A Skin-care face-beautying cream |
| 04/30/2003 | CN1107068C 2-amino-7-(1-substituted-2-hyroxyethyl)-3.5-diphydro-pyrrolo (3,2-D) pyrimidine-4-ones |
| 04/30/2003 | CN1107061C Chemotaxis cell factor receptor-3 receptor antagonists |
| 04/30/2003 | CN1107058C Subsitituted isoxazoles for treatment of inflammation |
| 04/30/2003 | CN1106854C Ointment for treating burn and scald and its preparation process |
| 04/30/2003 | CN1106841C Compositions for treatment of skin disorders |
| 04/30/2003 | CN1106833C Multifunctional Chinese medicine facial mask |
| 04/29/2003 | US6555710 Aminobenzophenones as inhibitors of IL-1 β and TNF-α |
| 04/29/2003 | US6555700 1,3-propane diol esters and ethers and methods for their use in drug delivery |
| 04/29/2003 | US6555651 Ligand binding site of rage and uses thereof |
| 04/29/2003 | US6555568 3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-N-acetic acid, ethyl ester for example; treating angiogenesis, hyperglycemia, hyperlipidemia and chronic complications arising from diabetes mellitus |
| 04/29/2003 | US6555542 Sulfonamide lactam inhibitors of FXa and method |
| 04/29/2003 | US6555532 Using estrogen receptor antagonists such as tamoxifen |
| 04/29/2003 | US6555519 O-glucosylated benzamide SGLT2 inhibitors and method |
| 04/29/2003 | US6555518 2',2'-difluoronucleosides for suppressing rejection of transplants in mammals; for treatment of autoimmune diseases |
| 04/29/2003 | US6555377 Process for production of mammalian cell lines |
| 04/29/2003 | US6555143 Soybean products having trypsin inhibitory activity and reduced microbial content for topical application to skin, nails, and hair |
| 04/25/2003 | CA2407217A1 Cosmetic use of dhea derivatives |
| 04/24/2003 | WO2003033720A2 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 04/24/2003 | WO2003033696A1 Vegf antisense compound |
| 04/24/2003 | WO2003033686A2 Keratinocytes which may be used as biologically active substances for the treatment of wounds |
| 04/24/2003 | WO2003033671A2 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 04/24/2003 | WO2003033528A1 Cyclic peptides as g-protein-coupled receptor antagonists |
| 04/24/2003 | WO2003033527A2 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 04/24/2003 | WO2003033524A2 Peptidyl ketones as inhibitors of dpiv |
| 04/24/2003 | WO2003033502A1 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/24/2003 | WO2003033499A2 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 04/24/2003 | WO2003033496A1 Beta-carbolin derivatives as ptp-inhibitors |
| 04/24/2003 | WO2003033487A1 Piperidine- and piperazineacetamines as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 04/24/2003 | WO2003033486A1 Novel substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 04/24/2003 | WO2003033483A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 04/24/2003 | WO2003033482A1 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003033481A1 Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them |
| 04/24/2003 | WO2003033478A1 Alkynylated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitors |
| 04/24/2003 | WO2003033470A1 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 04/24/2003 | WO2003033466A1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 04/24/2003 | WO2003033457A1 Biphenyl-derivatives as p38-kinase inhibitors |
| 04/24/2003 | WO2003033456A1 NOVEL β-PHENYL-α-OXYSUBSTITUTED PROPIONIC DERIVATIVES: PROCESS FOR ITS PREPARATION AND THEIR USE IN THE PREPARATION OF PHARMACEUTICALLY IMPORTANT COMPOUNDS |
| 04/24/2003 | WO2003033022A1 Use of oxaziridine derivatives and precursors in the treatment of dermatoses |
| 04/24/2003 | WO2003033017A1 Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone |
| 04/24/2003 | WO2003033010A1 Cyclosporin analogs for the treatment of autoimmune diseases |
| 04/24/2003 | WO2003033007A1 Pharmaceutical compositions for the topical use containing medicinal plants extracts with antiphlogistic and cicatrising activities |
| 04/24/2003 | WO2003032999A1 Alkyne matrix metalloproteinase inhibitors |
| 04/24/2003 | WO2003032997A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same |
| 04/24/2003 | WO2003032990A2 Polymer conjugates of opioid antagonists |
| 04/24/2003 | WO2003032989A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors |
| 04/24/2003 | WO2003032987A1 2'-methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032986A1 2' -methyl-5-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032985A2 Concomitant oral and topical administration of anti - infective agents |
| 04/24/2003 | WO2003032982A1 Bis-heteroaryl alkanes as therapeutic agents |
| 04/24/2003 | WO2003032980A1 5'-carbamoyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032976A1 Method of treating dermatoses using avermectin compound |
| 04/24/2003 | WO2003032971A1 5’-acylamino-1,1’-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032970A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032966A1 Compositions for potentiating glutatthione |
| 04/24/2003 | WO2003032964A2 Gap junctions and endothelial-derived hyperpolarizing factor (edhf) |
| 04/24/2003 | WO2003032946A2 Ph-sensitive liposomes for targeted drug delivery |
| 04/24/2003 | WO2003032944A1 Anti-microbial composition comprising a metal ion chelating agent |
| 04/24/2003 | WO2003032934A1 Cosmetic and/or pharmaceutical preparations |
| 04/24/2003 | WO2003032933A1 Cosmetic and/or pharmaceutical superfatting preparations |
| 04/24/2003 | WO2003032932A1 Hair repairing liquid comprising water dispersed with ultrafine particle titanium group metal by plasma underwater discharge and method and system for producing the same |